A Phase-I Study of Cisplatin Plus UCN-01 in Cancer Pat.

Beelen, Andrew P.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of General Medical Sciences (NIGMS)
• Type: Postdoctoral Individual National Research Service Award (F32)
• Project #: 5F32GM063269-02
• Application #: 6387317
• Study Section: Special Emphasis Panel (ZRG1-ET-1 (01))
• Program Officer: Somers, Scott D
• Project Start: 2001-08-29
• Budget Start: 2001-08-29
• Budget End: 2002-08-28
• Support Year: 2
• Fiscal Year: 2001
• Total Cost: $37,310

Institution

• Name: Dartmouth College
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 041027822
• City: Hanover
• State: NH
• Country: United States
• Zip Code: 03755

Publications

Lewis, Lionel D; Beelen, Andrew P; Cole, Bernard F et al. (2002) The pharmacokinetics of the bispecific antibody MDX-H210 when combined with interferon gamma-1b in a multiple-dose phase I study in patients with advanced cancer. Cancer Chemother Pharmacol 49:375-84

Beelen, A P; Yeo, K T; Lewis, L D (2001) Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone. Hum Exp Toxicol 20:215-9